By
Download on the App Store

episodes

  • Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 1 of 2)
    Part 1: Barriers to Optimizing the Use of Insulin in Managing Type 2 Diabetes
    In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding the barriers to optimizing the use of insulin in managing patients with type 2 diabetes. This installment is produced by ASHP Advantage and supported by Novo Nordisk Inc.
    Faculty:
    Curtis Triplitt, PharmD, CDE
    Associate Director, Diabetes Research Center, Texas Diabetes Institute
    Associate Professor, Department of Medicine, Division of Diabetes
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    Susan Cornell, PharmD, CDE, FAPhA, FAADE
    Associate Director of Experiential Education
    Associate Professor, Department of Pharmacy Practice
    Midwestern University Chicago College of Pharmacy
    Downers Grove, Illinois
    Joshua Neumiller, PharmD, CDE, FASCP
    Vice Chair and Associate Professor, Department of Pharmacotherapy
    Washington State University College of Pharmacy
    Spokane, Washington
    C.E. Credits: This activity is not eligible for continuing education credits.
    22 min
  • Individualizing Insulin Therapy for Type 2 Diabetes Mellitus (Part 2 of 2)
    Part 2: Future Treatment Options and Roles for Pharmacists in Individualizing Insulin Therapy
    In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Curtis L. Triplitt, Susan Cornell, and Joshua J. Neumiller regarding future treatment options for type 2 diabetes and the roles for pharmacists in individualizing insulin therapy. This installment is produced by A S H P Advantage and supported by Novo Nordisk Inc.
    Faculty:
    Curtis Triplitt, PharmD, CDE
    Associate Director, Diabetes Research Center, Texas Diabetes Institute
    Associate Professor, Department of Medicine, Division of Diabetes
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    Susan Cornell, PharmD, CDE, FAPhA, FAADE
    Associate Director of Experiential Education
    Associate Professor, Department of Pharmacy Practice
    Midwestern University Chicago College of Pharmacy
    Downers Grove, Illinois
    Joshua Neumiller, PharmD, CDE, FASCP
    Vice Chair and Associate Professor, Department of Pharmacotherapy
    Washington State University College of Pharmacy
    Spokane, Washington
    C.E. Credits: This activity is not eligible for continuing education credits.
    27 min
  • Biosimilars: Focus on Interchangeability and Integration into the Medication-use System (Part 2 of 2)
    In Part 2 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding biosimilars, focusing on interchangeability and the integration of biosimilars into the medication-use system.
    Faculty:
    Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair
    Associate Professor
    Department of Pharmacy Practice
    University of New England College of Pharmacy
    Portland, Maine
    James G. Stevenson, Pharm.D., FASHP
    Professor, Department of Clinical Pharmacy
    University of Michigan College of Pharmacy
    President, Hospital and Health System Services
    Visante, Inc.
    Ann Arbor, Michigan
    C.E. Credits: This activity is not eligible for continuing education credits.
    16 min
  • Biosimilars: Current Status in the European Union and United States (Part 1 of 2)
    In Part 1 of this two-part “Engaging the Experts” interview, William Zellmer talks with Edward Li and James Stevenson regarding the status of biosimilars in the European Union and United States.
    Faculty:
    Edward C. Li, Pharm.D., M.P.H., BCOP, Activity Chair
    Associate Professor
    Department of Pharmacy Practice
    University of New England College of Pharmacy
    Portland, Maine
    James G. Stevenson, Pharm.D., FASHP
    Professor, Department of Clinical Pharmacy
    University of Michigan College of Pharmacy
    President, Hospital and Health System Services
    Visante, Inc.
    Ann Arbor, Michigan
    C.E. Credits: This activity is not eligible for continuing education credits.
    19 min
  • Focus on SGLT2 inhibitors for Diabetes Part 2 of 2
    William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice.
    Faculty:
    Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair
    Assistant Director of Experiential Education
    Associate Professor
    Department of Pharmacy Practice
    Midwestern University Chicago College of Pharmacy
    Downers Grove, Illinois
    Curtis L. Triplitt, Pharm.D., CDE
    Associate Director, Diabetes Research Center, Texas Diabetes Institute
    Associate Professor, Department of Medicine, Division of Diabetes
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    C.E. Credits: This activity is not eligible for continuing education credits.
    10 min
  • Focus on SGLT2 inhibitors for Diabetes Part 1 of 2
    William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice.
    Faculty:
    Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair
    Assistant Director of Experiential Education
    Associate Professor
    Department of Pharmacy Practice
    Midwestern University Chicago College of Pharmacy
    Downers Grove, Illinois
    Curtis L. Triplitt, Pharm.D., CDE
    Associate Director, Diabetes Research Center, Texas Diabetes Institute
    Associate Professor, Department of Medicine, Division of Diabetes
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas
    C.E. Credits: This activity is not eligible for continuing education credits.
    8 min
  • Improving Hyponatremia Management Part 2 of 2
    William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement.
    Faculty:
    Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair
    Professor Emeritus
    The Ohio State University College of Pharmacy
    Adjunct Professor
    The University of Texas College of Pharmacy
    Austin, Texas
    Gretchen M. Brophy, Pharm.D., BCPS, FCCP, FCCM, FNCS
    Professor of Pharmacotherapy & Outcomes Science
    and Neurosurgery
    Virginia Commonwealth University
    Medical College of Virginia Campus
    Richmond, Virginia
    C.E. Credits: This activity is not eligible for continuing education credits.
    13 min
  • Improving Hyponatremia Management Part 1 of 2
    William Zellmer discusses issues related to improving hyponatremia management in hospitalized patients with Joseph Dasta and Gretchen Brophy. They explore how findings from a hyponatremia registry and disease-based medication-use evaluations of hyponatremia can help identify areas of patient care needing improvement.
    Faculty:
    Joseph F. Dasta, M.S., MCCM, FCCP, Activity Chair
    Professor Emeritus
    The Ohio State University College of Pharmacy
    Adjunct Professor
    The University of Texas College of Pharmacy
    Austin, Texas
    Gretchen M. Brophy, Pharm.D., BCPS, FCCP, FCCM, FNCS
    Professor of Pharmacotherapy & Outcomes Science
    and Neurosurgery
    Virginia Commonwealth University
    Medical College of Virginia Campus
    Richmond, Virginia
    C.E. Credits: This activity is not eligible for continuing education credits.
    13 min
  • New and Emerging Strategies for the Treatment of Advanced Melanoma
    William Zellmer discusses therapeutic options for treating patients with advanced melanoma with Christine Walko and R. Donald Harvey. They explore the epidemiology of melanoma including risk factors for developing the disease and discuss broad categories of new treatments and specific agents in each category.
    Faculty:
    Christine M. Walko, Pharm.D., BCOP, FCCP
    Clinical Pharmacogenomic Scientist
    Moffitt Cancer Center
    Associate Professor
    University of South Florida Morsani College of Medicine
    Tampa, Florida
    R. Donald Harvey, Pharm.D., FCCP, BCOP
    Associate Professor, Hematology/Medical Oncology
    Director, Phase 1 Clinical Trials Section
    Winship Cancer Institute
    Emory University
    Atlanta, Georgia
    C.E. Credits: This activity is not eligible for continuing education credits.
    17 min